{"disease":{"id":"mdd","name":"mdd"},"drugs":{"marketed":[{"drug_id":"vortioxetine","indication_name":"Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trintellix","generic_name":"vortioxetine","company_name":"Takeda","drug_phase":"marketed","molecular_target":"Serotonin transporter (SERT); 5-HT3 receptor; 5-HT1A receptor","drug_class":"Serotonin modulator and stimulator (SMS); SSRI-like agent","quality_score":78,"revenue":"800","mechanism":"Vortioxetine enhances serotonergic activity through serotonin reuptake inhibition with additional 5-HT3 antagonism and 5-HT1A agonism."},{"drug_id":"chembl-chembl894","indication_name":"Treatment of Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"BUPROPION","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"citalopram-hydrobromide","indication_name":"Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CITALOPRAM HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"bupropion-sr-150mg-bid","indication_name":"Treatment of Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupropion SR 150mg bid","company_name":"Massachusetts General Hospital","drug_phase":"marketed","molecular_target":"Dopamine transporter (DAT), Norepinephrine transporter (NET)","drug_class":"Atypical antidepressant, Norepinephrine-dopamine reuptake inhibitor (NDRI)","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"paroxetine","indication_name":"Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Paroxetine","generic_name":"paroxetine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Serotonin (5-HT) reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":73,"revenue":null,"mechanism":"Inhibits neuronal reuptake of serotonin in the central nervous system, presumed mechanism for treating psychiatric disorders."},{"drug_id":"bupropion-immediate-release-ir","indication_name":"Major Depressive Disorder (MDD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"bupropion immediate release (IR)","generic_name":"bupropion-immediate-release-ir","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Dopamine transporter, Norepinephrine transporter","drug_class":"Norepinephrine-dopamine reuptake inhibitor","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07015944","title":"Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan","phase":"NA","overall_status":"RECRUITING","enrollment_count":26376,"lead_sponsor_name":"Pakistan Institute of Living and Learning","has_results":false},{"nct_id":"NCT06699940","title":"A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents","phase":"","overall_status":"COMPLETED","enrollment_count":7690,"lead_sponsor_name":"Neuronetics","has_results":false},{"nct_id":"NCT05541302","title":"Retrospective TMS Therapy for Adults With MDD","phase":"","overall_status":"COMPLETED","enrollment_count":6456,"lead_sponsor_name":"Neuronetics","has_results":false},{"nct_id":"NCT06512324","title":"Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Biomedical Discoveries and Neuroscientific Foundations LLC","has_results":false},{"nct_id":"NCT07314190","title":"Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1799,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT07239843","title":"Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1310,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT01594996","title":"European Drug Utilization Study","phase":"","overall_status":"COMPLETED","enrollment_count":814,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06827431","title":"The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":770,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04853407","title":"A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT06771583","title":"Identification and Validation of Epigenetic Biomarkers of PMDD","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06749470","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study on the Treatment of Depression with Jieyu Chufan Capsules","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":480,"lead_sponsor_name":"Central South University","has_results":false},{"nct_id":"NCT07228468","title":"Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)","phase":"NA","overall_status":"RECRUITING","enrollment_count":438,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT06992167","title":"Caregiver Depression in a Low-Resource Setting: Socio-Demographic Predictors of Major Depressive Disorder Among Family Caregivers of Breast Cancer Patients in Pakistan","phase":"","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Rahmah Health Foundation","has_results":false},{"nct_id":"NCT06828887","title":"Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Vigonvita Life Sciences","has_results":false},{"nct_id":"NCT07444463","title":"Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Central South University","has_results":false},{"nct_id":"NCT07253207","title":"Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":392,"lead_sponsor_name":"Zhejiang Huahai Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06958692","title":"A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":388,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07164287","title":"Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":376,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT06467474","title":"Psychoeducational Group for Depression","phase":"NA","overall_status":"RECRUITING","enrollment_count":338,"lead_sponsor_name":"Ricardo Alberto Moreno, M.D., Ph.D.","has_results":false},{"nct_id":"NCT06793397","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"Cybin IRL Limited","has_results":false},{"nct_id":"NCT07452835","title":"Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT07479758","title":"Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03971305","title":"A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06704594","title":"Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":288,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06796868","title":"A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Beijing Greatway Pharmaceutical Technology Co.,Ltd.","has_results":false},{"nct_id":"NCT05966532","title":"Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":276,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT06746155","title":"Predictors of Relapse in Major Depressive Disorder","phase":"","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Abraham Nunes","has_results":false},{"nct_id":"NCT06842992","title":"A Phase II Study to Evaluate NH102 for Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":243,"lead_sponsor_name":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05762458","title":"The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05018013","title":"Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05437588","title":"Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents","phase":"NA","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT01111552","title":"Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":237,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT07226661","title":"Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":230,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07452692","title":"A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Corium Innovations, Inc.","has_results":false},{"nct_id":"NCT06836063","title":"Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Suven Life Sciences Limited","has_results":false},{"nct_id":"NCT01111539","title":"Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":211,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT06409325","title":"Effectiveness of MST Versus ECT for Major Depressive Episode","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT07328373","title":"Neurobiological and Genomic Predictors of Relapse in Depression","phase":"","overall_status":"RECRUITING","enrollment_count":204,"lead_sponsor_name":"Mehmet Kemal Arikan","has_results":false},{"nct_id":"NCT06976697","title":"Home-Based tDCS Treatment Of Major Depressive Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sooma Medical Inc","has_results":false},{"nct_id":"NCT05745194","title":"Influence of Nutrition in Depression Treatment (INDEPT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA","has_results":false},{"nct_id":"NCT01123707","title":"To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":173,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05657691","title":"Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Actinogen Medical","has_results":false},{"nct_id":"NCT06044818","title":"Validation of Accexible as a Tool for Screening and Monitoring Depression.","phase":"","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Accexible","has_results":false},{"nct_id":"NCT07283419","title":"Predictors of rTMS and Group Therapy Efficacy in Adolescent Depression","phase":"","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"The First Hospital of Hebei Medical University","has_results":false},{"nct_id":"NCT06821646","title":"Investigating the Brain's Physiological Responses in Depression and Autism, Using Transcranial Magnetic Stimulation and Electroencephalography","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07388849","title":"A Longitudinal Follow-Up Study on Predicting Major Depressive Disorder From Rest-Activity Rhythm Profiles","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07388004","title":"Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Philipps University Marburg","has_results":false},{"nct_id":"NCT05964023","title":"pBFS Guided VS \"5-cm Rule\" rTMS Over DLPFC for MDD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Changping Laboratory","has_results":false},{"nct_id":"NCT07234851","title":"Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":150,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}